Kristen Williams
CIK 1296965 · Lihat di SEC EDGAR ↗
Pengajuan SEC Pertama: 5 Juni 2026 · Terbaru: 5 Juni 2026
Di halaman ini
- Orang Dalam di Perusahaan di mana orang ini adalah orang dalam yang melaporkan.
- Transaksi orang dalam Setiap saham yang dibeli atau dijual orang ini, dari pengajuan Formulir 4.
- Derivatif Opsi dan kepemilikan derivatif lainnya yang dilaporkan oleh orang ini.
- Kepemilikan Awal Kepemilikan yang dimiliki orang ini saat pertama kali mulai melaporkan.
- Kompensasi Gaji eksekutif yang diungkapkan dalam pernyataan proksi perusahaan.
Orang Dalam di
Transaksi orang dalam
Perubahan harga vs kuotasi saat ini, disesuaikan split untuk aksi korporasi sejak pengajuan — tidak dibenchmark, tidak diannualisasi, tidak dibobot berdasarkan ukuran
| Tanggal | Ticker | Kode | Saham | Harga | Nilai | Dimiliki setelah | Δ milik | A/D | vs sekarang |
|---|---|---|---|---|---|---|---|---|---|
| 3 Juni 2026 | PCRX | S | 10.259 | $22,27 | $228.468 | 167.062 | — | — | 8,1% (harga per 2026-08-20) |
| 4 Juni 2025 | PCRX | S | 14.376 | $26,24 | $377.226 | 161.574 Langsung | -8,17% | Dilepas | -8,2% (harga per 2026-08-20) |
| 13 Juni 2024 | PCRX | S 10b5-1 | 7.452 | $28,38 | $211.488 | 102.912 Langsung | -6,75% | Dilepas | -15,1% (harga per 2026-08-20) |
| 14 Juni 2023 | PCRX | S 10b5-1 | 6.467 | $37,03 | $239.473 | 25.375 Langsung | -20,31% | Dilepas | -35,0% (harga per 2026-08-20) |
| 7 Juni 2023 | PCRX | S | 1.357 | $37,86 | $51.376 | 20.892 Langsung | -6,10% | Dilepas | -36,4% (harga per 2026-08-20) |
| 6 Juni 2023 | PCRX | S | 1.301 | $38,99 | $50.726 | 22.249 Langsung | -5,52% | Dilepas | -38,2% (harga per 2026-08-20) |
| 7 Juni 2022 | PCRX | S 10b5-1 | 4.649 | $59,51 | $276.662 | 13.650 Langsung | -25,41% | Dilepas | -59,5% (harga per 2026-08-20) |
| 6 Juni 2022 | PCRX | S 10b5-1 | 3.969 | $61,37 | $243.578 | 18.299 Langsung | -17,82% | Dilepas | -60,8% (harga per 2026-08-20) |
| 21 Maret 2022 | PCRX | S 10b5-1 | 7.253 | $72,67 | $527.076 | 22.268 Langsung | -24,57% | Dilepas | -66,9% (harga per 2026-08-20) |
| 25 Feb. 2022 | PCRX | S 10b5-1 | 50 | $65,00 | $3.250 | 24.268 Langsung | -0,21% | Dilepas | -62,9% (harga per 2026-08-20) |
| 25 Feb. 2022 | PCRX | S 10b5-1 | 2.000 | $67,07 | $134.140 | 22.268 Langsung | -8,24% | Dilepas | -64,1% (harga per 2026-08-20) |
| 16 Feb. 2022 | PCRX | S 10b5-1 | 10 | $65,00 | $650 | 22.268 Langsung | -0,04% | Dilepas | -62,9% (harga per 2026-08-20) |
| 10 Feb. 2022 | PCRX | S 10b5-1 | 800 | $65,18 | $52.144 | 22.268 Langsung | -3,47% | Dilepas | -63,0% (harga per 2026-08-20) |
| 4 Feb. 2022 | PCRX | S 10b5-1 | 1.000 | $65,18 | $65.180 | 22.268 Langsung | -4,30% | Dilepas | -63,0% (harga per 2026-08-20) |
| 21 Jan. 2022 | PCRX | S 10b5-1 | 200 | $65,41 | $13.082 | 22.268 Langsung | -0,89% | Dilepas | -63,2% (harga per 2026-08-20) |
| 19 Jan. 2022 | PCRX | S 10b5-1 | 2.199 | $65,51 | $144.056 | 22.268 Langsung | -8,99% | Dilepas | -63,2% (harga per 2026-08-20) |
| 18 Jan. 2022 | PCRX | S 10b5-1 | 400 | $66,14 | $26.456 | 22.268 Langsung | -1,76% | Dilepas | -63,6% (harga per 2026-08-20) |
| 18 Jan. 2022 | PCRX | S 10b5-1 | 23.040 | $65,24 | $1.503.130 | 22.668 Langsung | -50,41% | Dilepas | -63,1% (harga per 2026-08-20) |
| 10 Juni 2021 | PCRX | S 10b5-1 | 4.842 | $59,43 | $287.760 | 23.115 Langsung | -17,32% | Dilepas | -59,5% (harga per 2026-08-20) |
| 10 Juni 2021 | PCRX | S 10b5-1 | 847 | $60,57 | $51.303 | 22.268 Langsung | -3,66% | Dilepas | -60,2% (harga per 2026-08-20) |
| 4 Juni 2021 | PCRX | S | 3.930 | $61,04 | $239.887 | 20.957 Langsung | -15,79% | Dilepas | -60,5% (harga per 2026-08-20) |
| 13 April 2021 | PCRX | S 10b5-1 | 7.030 | $68,11 | $478.813 | 24.887 Langsung | -22,03% | Dilepas | -64,6% (harga per 2026-08-20) |
| 13 April 2021 | PCRX | S 10b5-1 | 14.793 | $66,40 | $982.255 | 31.917 Langsung | -31,67% | Dilepas | -63,7% (harga per 2026-08-20) |
| 17 Sep. 2020 | PCRX | S 10b5-1 | 3.200 | $60,22 | $192.704 | 24.887 Langsung | -11,39% | Dilepas | -60,0% (harga per 2026-08-20) |
| 17 Sep. 2020 | PCRX | S 10b5-1 | 24.671 | $59,77 | $1.474.586 | 28.087 Langsung | -46,76% | Dilepas | -59,7% (harga per 2026-08-20) |
| 16 Sep. 2020 | PCRX | S 10b5-1 | 21.244 | $60,33 | $1.281.651 | 24.887 Langsung | -46,05% | Dilepas | -60,1% (harga per 2026-08-20) |
| 16 Sep. 2020 | PCRX | S 10b5-1 | 6.609 | $59,54 | $393.500 | 46.131 Langsung | -12,53% | Dilepas | -59,5% (harga per 2026-08-20) |
| 15 Sep. 2020 | PCRX | S 10b5-1 | 13.231 | $59,80 | $791.214 | 24.887 Langsung | -34,71% | Dilepas | -59,7% (harga per 2026-08-20) |
| 15 Sep. 2020 | PCRX | S 10b5-1 | 14.622 | $59,01 | $862.844 | 38.118 Langsung | -27,72% | Dilepas | -59,2% (harga per 2026-08-20) |
Menampilkan 100 dari 140 transaksi terakhir
P = Pembelian pasar terbuka · S = Penjualan · A = Hibah/penghargaan · B = Pelaksanaan opsi · G = Hadiah · F = Pemotongan pajak
Transaksi orang dalam bukan merupakan rekomendasi; penjualan sering kali didorong oleh alasan likuiditas atau pajak.
Kepemilikan Derivatif (Formulir 4 Tabel II)
Opsi, RSU, dan sekuritas konversi yang dilaporkan pada Formulir 4 Tabel II.
| Tanggal | Ticker | Sekuritas | Underlying | Harga Pelaksanaan | Kedaluwarsa | Saham | A/D |
|---|---|---|---|---|---|---|---|
| 14 Juni 2023 | PCRX | Stock Option (Right to Buy) | Common Stock (27.500) | $38,74 | 14 Juni 2033 | 27.500 | Diakuisisi |
| 8 Juni 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (24.800) | $59,39 | 8 Juni 2032 | 24.800 | Diakuisisi |
| 21 Maret 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2.188) | $47,65 | 9 Juni 2030 | 2.188 | Dilepas |
| 21 Maret 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2.112) | $43,54 | 5 Juni 2029 | 2.112 | Dilepas |
| 21 Maret 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2.953) | $38,35 | 13 Juni 2028 | 2.953 | Dilepas |
| 25 Feb. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2.050) | $38,35 | 13 Juni 2028 | 2.050 | Dilepas |
| 16 Feb. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (10) | $38,35 | 13 Juni 2028 | 10 | Dilepas |
| 10 Feb. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (800) | $38,35 | 13 Juni 2028 | 800 | Dilepas |
| 4 Feb. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (1.000) | $38,35 | 13 Juni 2028 | 1.000 | Dilepas |
| 21 Jan. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (200) | $38,35 | 13 Juni 2028 | 200 | Dilepas |
| 19 Jan. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2.199) | $38,35 | 13 Juni 2028 | 2.199 | Dilepas |
| 18 Jan. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (13.127) | $47,65 | 9 Juni 2030 | 13.127 | Dilepas |
| 18 Jan. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (6.338) | $43,54 | 5 Juni 2029 | 6.338 | Dilepas |
| 18 Jan. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (2.600) | $38,35 | 13 Juni 2028 | 2.600 | Dilepas |
| 18 Jan. 2022 | PCRX | Stock Option (Right to Buy) | Common Stock (1.375) | $44,20 | 14 Juni 2027 | 1.375 | Dilepas |
| 9 Juni 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (17.500) | $60,96 | 9 Juni 2031 | 17.500 | Diakuisisi |
| 13 April 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (6.339) | $43,54 | 5 Juni 2029 | 6.339 | Dilepas |
| 13 April 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (8.859) | $38,35 | 13 Juni 2028 | 8.859 | Dilepas |
| 13 April 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (4.125) | $44,20 | 14 Juni 2027 | 4.125 | Dilepas |
| 13 April 2021 | PCRX | Stock Option (Right to Buy) | Common Stock (2.500) | $32,35 | 7 Des. 2026 | 2.500 | Dilepas |
| 17 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (2.819) | $43,54 | 5 Juni 2029 | 2.819 | Dilepas |
| 17 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (7.878) | $38,35 | 13 Juni 2028 | 7.878 | Dilepas |
| 17 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.502) | $44,20 | 14 Juni 2027 | 5.502 | Dilepas |
| 17 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.836) | $32,35 | 7 Des. 2026 | 5.836 | Dilepas |
| 17 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.836) | $40,34 | 15 Juni 2026 | 5.836 | Dilepas |
| 16 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (2.816) | $43,54 | 5 Juni 2029 | 2.816 | Dilepas |
| 16 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (7.874) | $38,35 | 13 Juni 2028 | 7.874 | Dilepas |
| 16 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.499) | $44,20 | 14 Juni 2027 | 5.499 | Dilepas |
| 16 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.832) | $32,35 | 7 Des. 2026 | 5.832 | Dilepas |
| 16 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.832) | $40,34 | 15 Juni 2026 | 5.832 | Dilepas |
| 15 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (2.816) | $43,54 | 5 Juni 2029 | 2.816 | Dilepas |
| 15 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (7.874) | $38,35 | 13 Juni 2028 | 7.874 | Dilepas |
| 15 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.499) | $44,20 | 14 Juni 2027 | 5.499 | Dilepas |
| 15 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.832) | $32,35 | 7 Des. 2026 | 5.832 | Dilepas |
| 15 Sep. 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (5.832) | $40,34 | 15 Juni 2026 | 5.832 | Dilepas |
| 9 Juni 2020 | PCRX | Stock Option (Right to Buy) | Common Stock (35.000) | $47,65 | 9 Juni 2030 | 35.000 | Diakuisisi |
| 5 Juni 2019 | PCRX | Stock Option (Right to Buy) | Common Stock (33.800) | $43,54 | 5 Juni 2029 | 33.800 | Diakuisisi |
| 13 Juni 2018 | PCRX | Stock Option (Right to Buy) | Common Stock (47.250) | $38,35 | 13 Juni 2028 | 47.250 | Diakuisisi |
| 17 Nov. 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (7.857) | $25,37 | 5 Maret 2023 | 7.857 | Dilepas |
| 16 Nov. 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (2.143) | $25,37 | 5 Maret 2023 | 2.143 | Dilepas |
| 14 Juni 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (22.000) | $44,20 | 14 Juni 2027 | 22.000 | Diakuisisi |
| 15 Mei 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (11.979) | $10,81 | 5 Juni 2022 | 11.979 | Dilepas |
| 15 Mei 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (5.937) | $10,52 | 2 Maret 2022 | 5.937 | Dilepas |
| 15 Mei 2017 | PCRX | Stock Option (Right to Buy) | Common Stock (3.125) | $9,25 | 19 Okt. 2021 | 3.125 | Dilepas |
| 7 Des. 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (20.000) | $32,35 | 7 Des. 2026 | 20.000 | Diakuisisi |
| 15 Juni 2016 | PCRX | Stock Option (Right to Buy) | Common Stock (17.500) | $40,34 | 15 Juni 2026 | 17.500 | Diakuisisi |
| 3 Juni 2015 | PCRX | Stock Option (Right to Buy) | Common Stock (15.000) | $79,43 | 3 Juni 2025 | 15.000 | Diakuisisi |
Harga pelaksanaan/konversi kosong jika tidak berlaku (misalnya, RSU).
Kepemilikan Awal (Formulir 3) 5 saham
Sekuritas yang dipegang saat pertama kali menjadi orang dalam, sesuai Formulir 3 SEC.
| Tanggal | Ticker | Sekuritas | Saham | Kepemilikan |
|---|---|---|---|---|
| 14 Okt. 2014 | PCRX | Stock Option (Right to Buy)→ Common Stock (3.125) | 3.125 | Langsung |
| 14 Okt. 2014 | PCRX | Stock Option (Right to Buy)→ Common Stock (5.937) | 5.937 | Langsung |
| 14 Okt. 2014 | PCRX | Stock Option (Right to Buy)→ Common Stock (11.979) | 11.979 | Langsung |
| 14 Okt. 2014 | PCRX | Stock Option (Right to Buy)→ Common Stock (10.000) | 10.000 | Langsung |
| 14 Okt. 2014 | PCRX | Stock Option (Right to Buy)→ Common Stock (40.000) | 40.000 | Langsung |
Kompensasi (DEF 14A)
Dicocokkan berdasarkan nama dari pernyataan proksi (DEF 14A) — verifikasi terhadap pengajuan.
PCRX
Chief Administrative Officer and Secretary| Tahun fiskal | Gaji | Bonus | Penghargaan saham | Penghargaan opsi | Insentif non-ekuitas | Perubahan Pensiun | Lainnya | Total |
|---|---|---|---|---|---|---|---|---|
| 2023 | $501.018 | $225.900 | $424.203 | $438.138 | — | — | $11.602 | $1.600.861 |
| 2022 | $457.046 | $330.400 | $587.961 | $621.240 | — | — | $12.188 | $2.008.835 |
| 2019 | $479.231 | $225.000 | $243.824 | $720.919 | — | — | $23.743 | $1.692.717 |
Angka-angka dari Tabel Kompensasi Ringkasan dalam pernyataan proksi perusahaan (DEF 14A). Kompensasi bukan merupakan rekomendasi.